Concepedia

Patrice Gill

PG

Statistics

Publications

14

Citations

412

H-Index

11

Active since

1981

Affiliations

Bristol-Myers Squibb (United States)(Current)

Bristol-Myers Squibb (Germany)

The University of Adelaide

Bristol-Myers Squibb (Canada)

Bristol-Myers Squibb (Sweden)

Patrice Gill is an author at Bristol-Myers Squibb (United States) specializing in pharmacology, medicine, and medicinal chemistry.

Publications per year

1981–2021

14

Publications

14

Discovery of Clinical Candidate BMS-906024: A Potent Pan-Notch Inhibitor for the Treatment of Leukemia and Solid Tumors

Ashvinikumar V. Gavai, Claude Quesnelle, Derek Norris et al. · ACS Medicinal Chemistry Letters · 2015 · 89 citations · Full text

, , +11

Difference between R5020 and the antiprogestin RU486 in antiproliferative effects on human breast cancer cells

Patrice Gill, Françoise Vignon, Sylvie Bardon et al. · Breast Cancer Research and Treatment · 1987 · 62 citations

, , +9

Discovery and Preclinical Pharmacology of an Oral Bromodomain and Extra-Terminal (BET) Inhibitor Using Scaffold-Hopping and Structure-Guided Drug Design

Ashvinikumar V. Gavai, Derek Norris, George V. Delucca et al. · Journal of Medicinal Chemistry · 2021 · 44 citations · Full text

, , +17

Discovery of isoxazolinone antibacterial agents. Nitrogen as a replacement for the stereogenic center found in oxazolidinone antibacterials

Lawrence B. Snyder, Zhaoxing Meng, Robert Mate et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 43 citations

, , +11

Synthesis of Enantiopure Arylkainoids: Preparation of (2S)-.DELTA.3-4-Phenylkainic Acid

Patrice Gill, William D. Lubell · The Journal of Organic Chemistry · 1995 · 29 citations

, , +5

1–5 of 14